Nanomedicine News

RSS

Two Finnish Life Science Companies Launch Upcon Upconverting Nanoparticle System

The life science field has seen numerous detection technologies come and go over the years. Some are shooting stars and others become the golden standard. Photon upconversion is a novel detection technology that has raised much enthusiasm among researchers during recent years.

3 Oct 2014

Researchers to Deliver Protection from Killer Diseases Using Nature’s Nanoparticles

Case Western Reserve University researchers hope to take a healthy salad up a level by growing a vaccine for an aggressive form of breast cancer in leafy greens.

3 Oct 2014

NanoViricides Announces Delivery of FluCide to BASi to Begin Toxicology Studies

NanoViricides, Inc. reports that it has shipped FluCide™ to BASi for the start of toxicology studies. NanoViricides has chosen BioAnalytical Systems Inc. Toxicology Services of West Lafayette, Indiana to perform our safety/toxicology studies as needed for an IND submission of the Injectable FluCide drug candidate.

From NanoViricides, Inc 3 Oct 2014

Superior Hybrid Gold Nanoparticle Cardiac Patch for Tissue Engineering

Because heart cells cannot multiply and cardiac muscles contain few stem cells, heart tissue is unable to repair itself after a heart attack. Now Tel Aviv University researchers are literally setting a new gold standard in cardiac tissue engineering.

1 Oct 2014

UCLA Re-Engineers Antibiotics to Enhance Activity Against Persister Cells

We face an urgent global health problem because scientists are not developing new antibiotics as fast as bacteria are developing antibiotic resistance.

30 Sep 2014

UNITAID Report on Tuberculosis Cites NanoLogix Detection Technology

NanoLogix Inc., an innovative biotechnology company in Northeastern Ohio announces that UNITAID, based in Geneva, Switzerland and hosted by the World Health Organization (WHO), on Friday published their Tuberculosis diagnostics technology and market landscape – 3rd edition. NanoLogix's sandwiched-membrane BNP rapid testing technology for tuberculosis is cited on pages 17 and 37 of the report.

From NanoLogix 30 Sep 2014

Researchers Develop New Technology to Inject RNA Carried by Lipidoid Nanoparticles

MIT engineers have devised a way to rapidly test hundreds of different drug-delivery vehicles in living animals, making it easier to discover promising new ways to deliver a class of drugs called biologics, which includes antibodies, peptides, RNA, and DNA, to human patients.

30 Sep 2014

Supersensitive Nanoprobe Sensor Enables Extremely Early Detection of Cancers

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville (UAH) in collaboration with The Joint School of Nanoscience and Nanoengineering (JSNN) in Greensboro, NC.

30 Sep 2014

Researchers Open and Close Nanovesicles Using a Magnet

Chemists and physicists of Radboud University managed to open and close nanovesicles using a magnet. This process is repeatable and can be controlled remotely, allowing targeted drug transport in the body, for example.

26 Sep 2014

Swissmedic Approves Celgene’s ABRAXANE for Treatment of Metastatic Pancreatic and Breast Cancers

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, today announced that Swissmedic, the regulatory authority for Switzerland, has granted approval for ABRAXANE® (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) as a treatment for metastatic pancreatic cancer (in combination with gemcitabine), and as a treatment for metastatic breast cancer.

25 Sep 2014